Alkali burn treated with 2% rebamipide ophthalmic suspension: A case report

7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the inferior third of the limbal conjunctiva, a total corneal epithelial defect and mild corneal stromal opacity, the damage was determined as Roper-Hall grade III. 2% rebamipide ophthalmic suspension, which is used for dry eye disease, was administered 4 times a day followed by conventional treatment for serious alkali injury. The corneal epithelial defect was resolved, and there were no side effects. The effectiveness of 2% rebamipide ophthalmic suspension in both the repair and improvement of the damage in the conjunctival and corneal epithelia, and its anti-inflammatory effect suggest that it may be an effective treatment not only for dry eye disease but also for alkali ocular damage.

Cite

CITATION STYLE

APA

Sasaki, H., & Kokubun, T. (2014). Alkali burn treated with 2% rebamipide ophthalmic suspension: A case report. Case Reports in Ophthalmology, 5(3), 380–385. https://doi.org/10.1159/000369201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free